Pharm Tech Minutes 2011.04.12-13

Attendees

Tuesday, April 12.

• Ana Estelrich, Phast
• Arianna Cocchiglia, Arsenal.it
• Jacqueline Surugue, EAHP
• Jose Costa Teixeira, Agfa Healthcare
• Jürgen Brandstätter, CodeWerk
• Leonidas Tzimis, EAHP
• Luca Zalunardo, Arsenal.it
• Marc Robberecht, Agfa Healthcare
• Marco Demarmels Lake Griffin LLC
• Orlando Rodrigues, Glintt
• Robert Breas, NICTIZ
• Robert Horn, Agfa Healthcare
• Simon Letellier, EAHP
• Tom de Jong, HL7 Pharmacy
• Viktor Hafner, Austrian Pharmacists Association

Wednesday, April 13.

• Ana Estelrich, Phast
• Arianna Cocchiglia, Arsenal.it
• Geert Claeys, Agfa Healthcare
• Jacqueline Surugue, EAHP
• Jose Costa Teixeira, Agfa Healthcare
• Jürgen Brandstätter, CodeWerk
• Leonidas Tzimis, EAHP
• Luca Zalunardo, Arsenal.it
• Marc Robberecht, Agfa Healthcare
• Marco Demarmels Lake Griffin LLC
• Orlando Rodrigues, Glintt
• Robert Breas, NICTIZ
• Simon Letellier, EAHP
• Viktor Hafner, Austrian Pharmacists Association

Greetings

This minutes are available in pdf format - 17 pages.

Presentation: XDW Profile

Presentation PDF format - 11 slides by Luca Zalunardo and Arianna Cocchiglia.

Report of vendors testing HMW profile

Representatives of vendors:

• Solinfo (Italy)
• Glintt (Portugal)
• Dedalus (Italy)

Report their feedback to the Pharmacy profiles and the Connectathon.

Presentation: Status of ePrescription/eDispensation in epSOS

The presentation by Marcello Melgara was based on epSOS ePrescription : functional service requirements (pdf document).

Roadmap: Discussing of Work-packages for 2011

COMMON

• Clinical trials

Linkage “Pharmacy” with current profiles dealing with clinical trial.

Discussion: Not most important, but in some hospitals a big time-consuming issue.

Decision: Start with a whitepaper what is needed for TC. Not this year.

• Handling instructions

e.g. Cold chain, ...

Discussion: If it’s an attribute of the product, of the supply chain or of part of Handling and Administration instructions.

Question: Shall Instructions be in prescriptions only or also in other documents. IHE must clarify the Technical Framework that this has been addressed.

Decision: Low priority but small task - This period if possible

• Linkage to “Vaccines/Immunizations”

Decision: Important, but not this year!

CMPD / HMW

• Workflow

Incorporate XDW Profile for missing workflow and status management -> Dependency issue with XDW roadmap.

Discussion: Very important especially for CMPD but a lot of work. Shall a whitepaper be written for the use of XDW in PHARM.

Decision: Urgent joint work XDW/PHARM beginning with a Whitepaper for use-cases. Confirmed by both WGs.

• Query current medication / Medication reconciliation

Discussion: It’s important how this is presented (text!). We can just deliver, what we “know” not what he actually “takes”. Be careful in phrasing this! Users have to be clear what they get and not get. HL7 introduced a “Medication statement”. Patient tells which medication he takes.

Decision: Most important use-case, should be in this period

• Substitution Handling: Exact Definition

Exact task: Work out and exactly clarify what a “Substitution is”.

Create samples.

Decision: In this period

• Use-case: Community - Hospital

Connection to Query current medication: At point of admission it shall be known the medication status

Several use-cases.

Is the current specification ready for covering these?

Decision: Creation of use-cases this period – then further decision

CMPD only

• Exceptional cases

e.g.: Prescription is not validated by pharmacist, Medication cannot be dispensed, etc. Results in writing specific use-cases and check if the current specification can handle them.

Decision: Some use-cases shall be created – then further decision

CONTENT PROFILES

• Substitution-Structure

There is still the open issue, that substitution handling could be stated different as current, using current HL7 MedicationOrder (PORX_RM010120UV) structures.

Open Issue

This element might change. Structure is still in discussion with PCC and HL7 Structured Document group.

Derived from "MedicationOrder" CMET (PORX_RM010120UV).

http://www.hl7.org/v3ballot/html/domains/uvrx/editable/PORX_RM010120UV.htm

Decision: Sidetrack, we have a solution. No pressure on it. Nice to have.

• Non-medication products

Same discussion in HL7.

Discussion: There is currently no harmonization in non-medication products (braces, bandages etc.) medical devices on international level. Such products don’t have a number, etc.

Decision: JB will check the optionalities to check, if current specification could carry such items. Then further decision.

• Preparations / Cytotoxics

Problem: Can be a mixture of everything (Products, Substances, other things). Problem is complex.

Decision: This period.

• Cancelling of already dispensed items which don’t have a prescription

Decision: This period.

• How to deal with dispenses on behalf of pre which are not here yet

Decision: This period.

Jose volunteers.

HMW only

• Message to be sent to many actors?

Decision: Not this year.

• HL7v2 question: Insufficient fields for Order, Order session, Prescription ...

Decision: Will be taken offline. Further discussed by Tom and Jose

• Administration report to dispenser – Purpose?

Decision: High priority

• Prescription protocols

Decision: Not much work, Jose volunteers

• Cytotoxics

Discussion: Impact on optionality, needs documenting.

Decision: Should be this year.

• Administration of perfusion

Decision: This year.

• Multiple systems in same hospital

e.g. Chemotherapy and normal pharmacy system

Decision: Draft solution this year, to see if good for inclusion

• Documents in hospital system?

Discussion: Too much work. This would result in a NEW profile.

Decision: Not this year. Currently no volunteers.

• Update to HL7v3 messages

Discussion: Would probably result in a new profile.

Decision: Not this year.

• Supply chain

Discussion: Big interest of vendors. It’s not about how to solve the supply chain, but how to “inform” the supply chain. A whitepaper should be written. Vendors should be involved. Is a cross-domain topic, possible liaison with ITI?

Decision: Whitepaper started this year.

• Referentials / Formularies

Discussion: It’s an implicit prerequisite in IHE to have common codelists and catalogs. Out of scope? Profiles should not require specific codesets, should be up to national extensions/specifications.

Decision: This assumption is sufficient.

• Exceptional cases

Discussion: e.g.: Prescription is not validated by pharmacist, Medication cannot be dispensed, etc.

Results in writing specific use-cases and check if the current specification can handle them.

Decision: Some use-cases shall be created – then further decision

Prioritizing

Changes in the work plan 2011-2012 (xls file)

Presentation: “FamaSafe”

Presentation in PDF format - 10 slides by Lapo Bertini (Dedalus, Italy) about their implementation of Pharmacy hospital profiles.

Planning next meetings

F2F meetings

• Paris/Vienna

Date: 28.-29.06.2011

• Vienna/Paris

Date: 04.-05.10.2011

Decision about Paris/Vienna switch triggered by Jacqueline depending on availability of guests.

Report of Jacqueline about this until next week -> then decision.

General compromise on future meeting places

• 3 F2F meetings per year:
  • 1 at the CAT
  • 1 at Paris or Brussels
  • 1 at an “other” location

List of candidates for future F2F on “other” location

1. Porto
2. Amsterdam/Den Haag
3. Treviso/Venice

Next TCons

Date: 24.05.2011 (moved from 19.05.2011),

Time: 12:00-13:30 Brussels time

General decisions about TCons

Duration will be extended from 1 h to 1,5 h

Miscellaneous

Liaison with epSOS

Michiel Sprenger is involved in epSOS WP 2.2 “Strategy and Policy”, deals with roadmap views, etc.

He could be the link from IHE Pharmacy to epSOS.

Decision: If this is an official liaison or informal will be checked by Robert Breas.

Meeting requested by Nick Brown

Jacqueline Surugue received an email of Nick Brown (IHE UK).

He would like to meet Pharmacy group at CAT Pisa.

Jürgen will do the meeting in Thursday.